Clinical Trial Update: 18F-Pentixafor PET in Hematologic Malignancies

View source ↗

Summary

This entry reports an ongoing clinical trial evaluating 18F-Pentixafor PET imaging in hematologic malignancies, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• 18F-Pentixafor (18F-pentixafor radiotracer)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Hematological Malignancies | Status: RECRUITING